Scorpionfish BPI is highly active against multiple drug-resistant
Jonas Maurice Holzinger, Martina Toelge, Maren Werner, Katharina Ursula Ederer, Heiko Ingo Siegmund, David Peterhoff, Stefan Helmut Blaas, Nicolas Gisch, Christoph Brochhausen, André Gessner and 1 more
Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 5 institutions in 2 countries.
Jonas Maurice HolzingerInstitute of Clinical Microbiology and Hygiene Regensburg, University Hospital Regensburg, Regensburg, Germany.ORCID 0009-0007-3274-7837
Martina ToelgeInstitute of Clinical Microbiology and Hygiene Regensburg, University Hospital Regensburg, Regensburg, Germany.
Maren WernerInstitute of Clinical Microbiology and Hygiene Regensburg, University Hospital Regensburg, Regensburg, Germany.
Katharina Ursula EdererInstitute of Clinical Microbiology and Hygiene Regensburg, University Hospital Regensburg, Regensburg, Germany.
Heiko Ingo SiegmundInstitute of Pathology, University of Regensburg, Regensburg, Germany.
David PeterhoffInstitute of Clinical Microbiology and Hygiene Regensburg, University Hospital Regensburg, Regensburg, Germany.
Stefan Helmut BlaasDepartment of Pneumology, Donaustauf Hospital, Donaustauf, Germany.
Nicolas GischDivision of Bioanalytical Chemistry, Priority Area Infections, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.ORCID 0000-0003-3260-5269
Christoph BrochhausenInstitute of Pathology, University of Regensburg, Regensburg, Germany.
André GessnerInstitute of Clinical Microbiology and Hygiene Regensburg, University Hospital Regensburg, Regensburg, Germany.ORCID 0000-0003-4316-2408
Sigrid BülowInstitute of Clinical Microbiology and Hygiene Regensburg, University Hospital Regensburg, Regensburg, Germany.ORCID 0000-0002-8952-290X
University Hospital Regensburg · DEHeidelberg University · DEKlinik Donaustauf · DEResearch Center Borstel - Leibniz Lung Center · DEUniversity of Regensburg · DE
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Chronic pulmonary infection is a hallmark of cystic fibrosis (CF) and requires continuous antibiotic treatment. In this context,
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Scorpionfish BPI is highly active against multiple drug-resistant · full record | OpenQuestion